Category: Clinical Breakthroughs
-
Novel Drug May Remedy Antibiotic Resistant Infections
A novel antibiotic drug showed similar treatment effectiveness compared to current therapies in patients with antibiotic resistant bacterial infections, according to two complementary clinical trials.
-
Novel Drug May Improve Treatment for Duchenne Muscular Dystrophy
A novel drug may improve the efficacy of corticosteroid treatment for patients with Duchenne muscular dystrophy and overall quality of life, according to a recent clinical trial.
-
Immunotherapy Effective in Hodgkin Lymphoma
A brief course of immunotherapy resulted in complete and near complete remission in nearly two-thirds of previously untreated patients with classical Hodgkin lymphoma, according to a Northwestern Medicine trial.
-
Wireless Monitoring Informs Acid Reflux Therapy
Measuring acid reflux with a wireless electrode can help clinicians determine if patients can stop taking proton pump inhibitors, a medication commonly prescribed for gastroesophageal reflux disease.
-
Novel Drug May Increase Bone Growth in Children with Achondroplasia
A first of its kind drug called vosoritide may increase bone growth in children with achondroplasia, the most common form of dwarfism, according to findings from a recent clinical trial.
-
Antibiotic Treatment for Appendicitis Shows Similar Patient Outcomes as Surgery
A nationwide clinical trial has found that patients taking antibiotics for appendicitis reported the same quality of life measures as those who underwent surgery.
-
Utilizing B-Cells to Promote Glioblastoma Immunity
Northwestern investigators have developed a novel vaccine that utilizes a specialized group of B-cells to promote anti-tumor immunity against glioblastoma.
-
Drug May Delay Progression of Ovarian Cancer
The drug rucaparib significantly delayed cancer progression for women with ovarian cancer and may be an effective option for maintenance therapy, according to findings from a recent clinical trial.
-
New Chemotherapy Alternative for Lymphoma
A new immunotherapy treatment for recurrent B-cell lymphoma was found to be safe in a trial of nearly 350 patients, according to a study published in The Lancet.
-
Earlier Treatment May Reduce Cardiovascular Disease
Starting cholesterol-lowering treatment earlier may increase the its benefits, reducing heart attack and stroke over time, according to a Northwestern Medicine study.
